Bank of New York Mellon’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$90.3M Sell
1,278,196
-480,923
-27% -$26M 0.01% 724
2026
Q1
$91.9M Sell
1,759,119
-31,568
-2% -$1.89M 0.02% 678
2025
Q4
$105M Sell
1,790,687
-139,355
-7% -$8.47M 0.02% 625
2025
Q3
$107M Buy
1,930,042
+6,950
+0.4% +$372K 0.02% 612
2025
Q2
$98.9M Sell
1,923,092
-491,279
-20% -$24.7M 0.02% 638
2025
Q1
$142M Sell
2,414,371
-16,938
-0.7% -$1.15M 0.03% 470
2024
Q4
$175M Sell
2,431,309
-11,006
-0.5% -$808K 0.03% 411
2024
Q3
$195M Sell
2,442,315
-272,071
-10% -$20.4M 0.04% 388
2024
Q2
$194M Sell
2,714,386
-148,140
-5% -$10.9M 0.04% 381
2024
Q1
$201M Buy
2,862,526
+351,645
+14% +$25.2M 0.04% 379
2023
Q4
$194M Buy
2,510,881
+34,329
+1% +$2.26M 0.04% 381
2023
Q3
$169M Buy
2,476,552
+300,903
+14% +$23.8M 0.04% 407
2023
Q2
$178M Sell
2,175,649
-101,581
-4% -$8.17M 0.04% 405
2023
Q1
$169M Sell
2,277,230
-57,196
-2% -$4.41M 0.04% 417
2022
Q4
$193M Buy
2,334,426
+219,022
+10% +$17.4M 0.04% 371
2022
Q3
$150M Sell
2,115,404
-41,032
-2% -$3.55M 0.04% 446
2022
Q2
$187M Buy
2,156,436
+42,740
+2% +$4.01M 0.04% 381
2022
Q1
$229M Buy
2,113,696
+358,972
+20% +$37M 0.04% 372
2021
Q4
$227M Sell
1,754,724
-65,960
-4% -$8.09M 0.04% 391
2021
Q3
$221M Sell
1,820,684
-317,492
-15% -$38.6M 0.04% 380
2021
Q2
$241M Buy
2,138,176
+29,040
+1% +$3.06M 0.05% 339
2021
Q1
$201M Buy
2,109,136
+467,484
+28% +$42.6M 0.04% 398
2020
Q4
$130M Sell
1,641,652
-177,936
-10% -$12.9M 0.03% 539
2020
Q3
$113M Sell
1,819,588
-35,596
-2% -$2.32M 0.03% 524
2020
Q2
$122M Buy
1,855,184
+55,388
+3% +$3.32M 0.03% 456
2020
Q1
$85.3M Buy
1,799,796
+11,152
+0.6% +$558K 0.03% 525
2019
Q4
$98.2M Sell
1,788,644
-43,032
-2% -$2.26M 0.03% 616
2019
Q3
$89.6M Sell
1,831,676
-44,372
-2% -$2.22M 0.02% 632
2019
Q2
$97.8M Buy
1,876,048
+26,996
+1% +$1.36M 0.03% 613
2019
Q1
$91.8M Sell
1,849,052
-54,112
-3% -$2.44M 0.03% 624
2018
Q4
$68.9M Sell
1,903,164
-140,480
-7% -$5.87M 0.02% 712
2018
Q3
$104M Buy
2,043,644
+21,868
+1% +$969K 0.03% 605
2018
Q2
$74.8M Sell
2,021,776
-14,304
-0.7% -$546K 0.02% 751
2018
Q1
$76.9M Buy
2,036,080
+84,092
+4% +$2.97M 0.02% 736
2017
Q4
$63.2M Sell
1,951,988
-53,280
-3% -$1.69M 0.02% 858
2017
Q3
$60.6M Buy
2,005,268
+10,792
+0.5% +$320K 0.02% 867
2017
Q2
$58.6M Buy
1,994,476
+16,640
+0.8% +$455K 0.02% 864
2017
Q1
$50.3M Buy
1,977,836
+80,256
+4% +$2.07M 0.01% 958
2016
Q4
$48.8M Buy
1,897,580
+74,948
+4% +$1.97M 0.01% 952
2016
Q3
$49.9M Buy
1,822,632
+2,076
+0.1% +$57K 0.01% 886
2016
Q2
$51.3M Sell
1,820,556
-40,636
-2% -$1.04M 0.02% 841
2016
Q1
$44M Buy
1,861,192
+54,688
+3% +$1.2M 0.01% 939
2015
Q4
$40.6M Sell
1,806,504
-54,852
-3% -$1.25M 0.01% 954
2015
Q3
$43M Buy
1,861,356
+50,500
+3% +$1.27M 0.01% 929
2015
Q2
$44.6M Buy
1,810,856
+66,676
+4% +$1.66M 0.01% 964
2015
Q1
$43.7M Buy
1,744,180
+81,744
+5% +$1.94M 0.01% 976
2014
Q4
$38.4M Sell
1,662,436
-62,068
-4% -$1.42M 0.01% 1049
2014
Q3
$40.3M Buy
1,724,504
+53,588
+3% +$1.26M 0.01% 998
2014
Q2
$38.7M Sell
1,670,916
-27,912
-2% -$617K 0.01% 1058
2014
Q1
$36.3M Buy
1,698,828
+8,764
+0.5% +$197K 0.01% 1088
2013
Q4
$40M Sell
1,690,064
-28,464
-2% -$617K 0.01% 1012
2013
Q3
$34.4M Sell
1,718,528
-212,668
-11% -$4.04M 0.01% 1068
2013
Q2
$33.4M Buy
+1,931,196
New +$32.1M 0.01% 1053

Other funds holding TECH

Bank of New York Mellon's TECH Position: Q2 2026 in Review

Bank of New York Mellon reduced its Bio-Techne (TECH) stake by 27% in Q2 2026, selling an estimated $26M and leaving 1,278,196 shares worth $90.3M. The position accounts for 0.01% of the portfolio, ranked #724.

Bank of New York Mellon first reported a position in TECH in Q2 2013 and has held it in 53 quarters since. The position peaked at $241M in Q2 2021. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Bank of New York Mellon held 1,278,196 shares of Bio-Techne worth $90.3M as of Q2 2026.
  • Bank of New York Mellon sold 480,923 Bio-Techne shares in Q2 2026, an estimated $26M.
  • Bio-Techne made up 0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #724 holding.
  • Bank of New York Mellon first reported a position in Bio-Techne in Q2 2013 and has held it in 53 quarters since.
  • Bank of New York Mellon's Bio-Techne position peaked at $241M in Q2 2021.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.